Natco Pharma Limited-RE Valuation

NATCO-RE · Healthcare · Current price ₹25.95

Full stock page
DocStoX fair value
Not published yet
No estimate for NATCO-RE at this time
Current price
₹26
P/E ratio
—
P/B ratio
—
Model it yourself — Earnings Yield Calculator
Opens pre-filled with Natco Pharma Limited-RE's latest numbers.

Is Natco Pharma Limited-RE undervalued?

We have not published a fair value estimate for Natco Pharma Limited-RE yet. Our valuation engine covers the market in waves, and this company has not been through a run that met our publishing bar. Rather than show a second, inconsistent number here, we would rather show none. The ratios, peer comparison and methodology below are still based on Natco Pharma Limited-RE's reported financials.

Valuation multiples

Natco Pharma Limited-RE trades at a P/E of — and a P/B of —. Multiples are most useful compared against the company's own history and its sector peers — see the peer comparison for context.

How we estimate fair value

When we publish an estimate for Natco Pharma Limited-RE, it will appear here with the full working: the models used and their weights, every assumption and its source, the confidence band, and what data was missing. That is the same methodology we apply to every company.

Read the full fair-value methodology

Understand the ratios

P/E RatioP/B RatioPEG RatioEarnings Yield

More on Natco Pharma Limited-RE

Fair ValueIntrinsic ValueDCFPeers

DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.